Japan Specialist

Mark Chadwick

Over 20 years experience in equities and asset management in Asia and Japan. Qualified CFA with experience analyzing companies as a buy-side analyst. In-depth knowledge of company fundamental analysis, corporate governance and valuations.

Consolidation in the Med-Tech Sector? Eiken and Hogy to Benefit

Japan Weekly | Stocks Take a Break After Rising +17% in Q1

Hogy Medical (3593) | New Strategy Sparks Investor Confidence

Equity Bottom-Up

<ul>
<li>Two activist investors are now on the shareholder registry of Eiken Chemical. </li>
<li>Eiken has proactively announced a share buyback to return excess cash holdings. </li>
<li>Eiken has a quality underlying business which generates solid FCF yield. Expect higher shareholder returns in the future. </li>
</ul>


Two activist investors are now on the shareholder registry of Eiken Chemical. 
Eiken has proactively announced a share buyback to return excess cash holdings. 
Eiken has a quality underlying business which generates solid FCF yield. Expect higher shareholder returns in the future. 


Eiken Chemical (4549) | Activists, Alchemy, and the Pursuit of Profit